Search hospitals > Massachusetts > Boston
Massachusetts Eye and Ear Infirmary
Claim this profileBoston, Massachusetts 02114
Global Leader in Hearing Loss
Conducts research for Glaucoma
Conducts research for Eye Diseases
Conducts research for Age-Related Macular Degeneration
Conducts research for Melanoma
136 reported clinical trials
16 medical researchers
Summary
Massachusetts Eye and Ear Infirmary is a medical facility located in Boston, Massachusetts. This center is recognized for care of Hearing Loss, Glaucoma, Eye Diseases, Age-Related Macular Degeneration, Melanoma and other specialties. Massachusetts Eye and Ear Infirmary is involved with conducting 136 clinical trials across 205 conditions. There are 16 research doctors associated with this hospital, such as Kristina Simonyan, MD, PhD, Ula Jurkunas, MD, Michael Cohen, MD, and D. Bradley Welling, MD, PhD.Top PIs
Kristina Simonyan, MD, PhDMassachusetts Eye and Ear Infirmary2 years of reported clinical research
Studies Hoarseness
Studies Dystonia
7 reported clinical trials
9 drugs studied
Ula Jurkunas, MDMassachusetts Eye and Ear Infirmary3 years of reported clinical research
Studies Corneal Dystrophies
Studies Fuchs' Dystrophy
3 reported clinical trials
5 drugs studied
Michael Cohen, MDMassachusetts Eye and Ear5 years of reported clinical research
Studies Hearing Loss
Studies Sensorineural Hearing Loss
2 reported clinical trials
2 drugs studied
D. Bradley Welling, MD, PhDMassachusetts Eye and Ear Infirmary3 years of reported clinical research
Studies Acoustic Neuroma
Studies Morton's Neuroma
2 reported clinical trials
3 drugs studied
Clinical Trials running at Massachusetts Eye and Ear Infirmary
Age-Related Macular Degeneration
Dystonia
Glaucoma
Fuchs' Dystrophy
Acoustic Neuroma
Retinal Detachment
Ocular Hypertension
Hoarseness
Corneal Dystrophies
Sleep Apnea
RGX-314 Gene Therapy
for Age-Related Macular Degeneration
RGX-314 is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular degeneration (wet AMD). Wet AMD is characterized by loss of vision due to new, leaky blood vessel formation in the retina. Wet AMD is a significant cause of vision loss in the United States, Europe and Japan, with up to 2 million people living with wet AMD in these geographies alone. Current anti-VEGF therapies have significantly changed the landscape for treatment of wet AMD, becoming the standard of care due to their ability to prevent progression of vision loss in the majority of patients. These therapies, however, require life-long intraocular injections, typically repeated every four to 12 weeks in frequency, to maintain efficacy. Due to the burden of treatment, patients often experience a decline in vision with reduced frequency of treatment over time. RGX-314 is being developed as a potential one-time treatment for wet AMD.
Recruiting2 awards Phase 32 criteria
KHK4951
for Age-Related Macular Degeneration
The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with nAMD.
Recruiting1 award Phase 24 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Massachusetts Eye and Ear Infirmary?
Massachusetts Eye and Ear Infirmary is a medical facility located in Boston, Massachusetts. This center is recognized for care of Hearing Loss, Glaucoma, Eye Diseases, Age-Related Macular Degeneration, Melanoma and other specialties. Massachusetts Eye and Ear Infirmary is involved with conducting 136 clinical trials across 205 conditions. There are 16 research doctors associated with this hospital, such as Kristina Simonyan, MD, PhD, Ula Jurkunas, MD, Michael Cohen, MD, and D. Bradley Welling, MD, PhD.